We are live on ! Find out more
NSEDCP

NJ State Employees Deferred Compensation Plan Portfolio holdings

AUM $906M
1-Year Est. Return 24.85%
This Fund
S&P 500
This Quarter Est. Return
-8.2%
1 Year Est. Return
+24.85%
3 Year Est. Return
+127.22%
5 Year Est. Return
+201.43%
10 Year Est. Return
+564.84%
AUM
$462M
AUM Growth
-$51.6M
Cap. Flow
-$441K
Cap. Flow %
-0.1%
Top 10 Hldgs %
15.6%
Holding
395
New
18
Increased
8
Reduced
14
Closed
13

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$2.31M
2
ABBV icon
AbbVie
ABBV
+$1.95M
3
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
+$1.27M
4
GERN icon
Geron
GERN
+$1.18M
5
KHC icon
Kraft Heinz
KHC
+$1.16M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$1.93M
2
AMAG
AMAG Pharmaceuticals
AMAG
+$1.86M
3
AEC
ASSOCIATED ESTATES REALTY CORP
AEC
+$1.72M
4
KRFT
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
+$1.3M
5
PLL
PALL CORP
PLL
+$1.25M

Sector Composition

Rank Sector Weight
1 Technology 16.61%
2 Financials 14.94%
3 Healthcare 14.92%
4 Industrials 11.55%
5 Consumer Staples 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AVP
376
DELISTED
Avon Products, Inc.
AVP
$49K 0.01%
15,000
– –
BSTG
377
DELISTED
Biostage, Inc. Common Stock
BSTG
$42K 0.01%
50,000
– –
AMD icon
378
Advanced Micro Devices
AMD
$776B
$29K 0.01%
17,000
– –
CRC
379
DELISTED
California Resources Corporation
CRC
$26K 0.01%
1,000
– –
AKS
380
DELISTED
AK Steel Holding Corp
AKS
$24K 0.01%
10,000
– –
KMI.WS
381
DELISTED
Kinder Morgan Inc
KMI.WS
$24K 0.01%
26,117
– –
EXXI
382
DELISTED
ENERGY XXI LTD COM SHS
EXXI
$21K ﹤0.01%
20,000
– –
CARM
383
DELISTED
Carisma Therapeutics
CARM
– –
-1,250
Closed -$70K
DHR icon
384
Danaher
DHR
$137B
– –
-14,878
Closed -$856K
PLX icon
385
Protalix BioTherapeutics
PLX
$191M
– –
-4,000
Closed -$78K
DISCK
386
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
– –
-7,500
Closed -$233K
XLRN
387
DELISTED
Acceleron Pharma
XLRN
– –
-7,000
Closed -$221K
SHLM
388
DELISTED
Schulman (A.) Inc
SHLM
– –
-6,000
Closed -$262K
HSP
389
DELISTED
HOSPIRA INC
HSP
– –
-7,000
Closed -$621K
PLL
390
DELISTED
PALL CORP
PLL
– –
-10,000
Closed -$1.25M
AEC
391
DELISTED
ASSOCIATED ESTATES REALTY CORP
AEC
– –
-60,000
Closed -$1.72M
ROSE
392
DELISTED
ROSETTA RESOURCES INC
ROSE
– –
-15,000
Closed -$347K
KRFT
393
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
– –
-15,329
Closed -$1.3M
WLL
394
DELISTED
Whiting Petroleum Corporation
WLL
– –
-32
Closed -$327K
RTI
395
DELISTED
RTI INTL METALS INC(HLDG CO)
RTI
– –
-25,000
Closed -$788K
12 13 14 15
16

Similar funds

IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
BFS
Bard Financial Services Branford, Connecticut $911M AUM 19.14% 1-Year Est. Return
MSAM
Moloney Securities Asset Management Manchester, Missouri $840M AUM 18.11% 1-Year Est. Return
SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return
CP
Coho Partners Berwyn, Pennsylvania $779M AUM 4.46% 1-Year Est. Return
EAM
EFG Asset Management Portland, Oregon $773M AUM 40.1% 1-Year Est. Return
HWM
Hemington Wealth Management Falls Church, Virginia $769M AUM 13.16% 1-Year Est. Return
BVDMP
Bedrijfstakpensioenfonds Voor De Media PNO Hilversum, Netherlands $759M AUM 19.37% 1-Year Est. Return

NJ State Employees Deferred Compensation Plan's Q3 2015 Portfolio in Review

As of Q3 2015, NJ State Employees Deferred Compensation Plan held 395 positions worth $462M, down 10% from $514M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

NJ State Employees Deferred Compensation Plan's Q3 2015 filing shows 18 new, 8 increased, 14 reduced and 13 closed positions. Its largest new stake was Biogen: 7,000 shares worth $2.04M. The largest sale was Johnson & Johnson, an estimated $1.93M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

  • NJ State Employees Deferred Compensation Plan's largest Q3 2015 buy was Biogen: 7,000 shares worth $2.04M.
  • NJ State Employees Deferred Compensation Plan added most to AbbVie in Q3 2015, an estimated $1.95M increase.
  • NJ State Employees Deferred Compensation Plan's biggest Q3 2015 reduction was Johnson & Johnson, cutting an estimated $1.93M.
  • NJ State Employees Deferred Compensation Plan fully exited ASSOCIATED ESTATES REALTY CORP in Q3 2015, selling an estimated $1.72M.
  • NJ State Employees Deferred Compensation Plan's ten largest holdings make up 16% of its $462M portfolio in Q3 2015.
  • NJ State Employees Deferred Compensation Plan opened 18 new positions and closed 13 in Q3 2015.
  • NJ State Employees Deferred Compensation Plan's portfolio value fell 10% quarter-over-quarter to $462M.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q3 2015, filed 2 Nov 2015.